QSV Biologics Signs GMP Deal

Biologic drugs contract manufacturer QSV Biologics (Calgary, AB) says it has secured a cGMP manufacturing contract with an undisclosed biopharma company based in California. Financial terms were not disclosed. The contract involves production of a recombinant therapeutic protein at a volume sufficient for human clinical trials. QSV says it will be responsible for technology transfer and cGMP manufacture of the product, which it will carry out at its Edmonton, AB...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers